Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)

FairStock Score: 47/100 — MIXED

Key Financials

Strengths

• Generates $617,000 in annual free cash flow (0.3% yield on market cap)
• Conservative balance sheet with debt-to-equity of just 0.04, providing financial flexibility
• Altman Z-Score of 8.7 confirms minimal bankruptcy risk and strong solvency
• Revenue growth of 150.4% demonstrates strong top-line momentum

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Sol-Gel Technologies Ltd. Ordinary Shares is a micro-cap healthcare company valued at $229 million. Revenue stands at $19 million, though the company is currently unprofitable. From a quality standpoint, Sol-Gel shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and Altman Z-Score of 8.7 confirms fortress-level solvency. On valuation, the stock is 0.3% FCF yield. Growth dynamics show revenue growing at 150.4% and profit growth of 48.9%. Our composite FairStock Score of 47/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Sol-Gel's 150% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $617,000 in annual free cash flow (0.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer